US · Healthcare

Khiron Life Sciences Corp (KHRNF)

Drug Manufacturers - Specialty & Generic

Khiron Life Sciences Corp (KHRNF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KHRNF

P/E ratio

18.00

Khiron Life Sciences Corp (KHRNF) — FAQ

What is KHRNF's P/E ratio?

The price-to-earnings (P/E) ratio for Khiron Life Sciences Corp (KHRNF) is 18.00 (data as of 2026-03-24).

Does Khiron Life Sciences Corp pay a dividend?

Dividend yield is not available in the current snapshot for Khiron Life Sciences Corp (KHRNF). Check the MyAverix Finance app for the latest dividend data.

What sector is Khiron Life Sciences Corp in?

Khiron Life Sciences Corp (KHRNF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is KHRNF listed on?

KHRNF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)